17-82322249-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003004.3(SECTM1):c.659C>T(p.Pro220Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000908 in 1,607,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003004.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SECTM1 | ENST00000269389.8 | c.659C>T | p.Pro220Leu | missense_variant | Exon 5 of 5 | 1 | NM_003004.3 | ENSP00000269389.3 | ||
SECTM1 | ENST00000580437 | c.*103C>T | 3_prime_UTR_variant | Exon 5 of 5 | 2 | ENSP00000463904.1 | ||||
SECTM1 | ENST00000581864.5 | n.*420C>T | non_coding_transcript_exon_variant | Exon 5 of 5 | 3 | ENSP00000464111.1 | ||||
SECTM1 | ENST00000581864.5 | n.*420C>T | 3_prime_UTR_variant | Exon 5 of 5 | 3 | ENSP00000464111.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 25AN: 247772Hom.: 0 AF XY: 0.000105 AC XY: 14AN XY: 133956
GnomAD4 exome AF: 0.0000845 AC: 123AN: 1455300Hom.: 0 Cov.: 31 AF XY: 0.0000830 AC XY: 60AN XY: 722868
GnomAD4 genome AF: 0.000151 AC: 23AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.659C>T (p.P220L) alteration is located in exon 5 (coding exon 4) of the SECTM1 gene. This alteration results from a C to T substitution at nucleotide position 659, causing the proline (P) at amino acid position 220 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at